AIMS AND BACKGROUND: In addition to nausea and vomiting following chemotherapy treatment, cancer patients can experience these side effects prior to a treatment session, the so-called anticipatory nausea and vomiting. As various psychological and neurophysiological aspects have been claimed to be implied in its etiopathogenesis, the present paper aims to shortly review the etiological, epidemiological and therapeutical assumptions on the topic, in particular the psychological-behavioral therapies. PATIENTS AND METHODS: The present study was carried out on 16 consecutive adult cancer patients affected by chemotherapy-induced anticipatory nausea and vomiting who had received at least four treatment cycles. All of them were submitted to induction of relaxation followed by hypnosis. RESULTS: In all subjects anticipatory nausea and vomiting disappeared, and major responses to chemotherapy-induced emesis control were recorded in almost all patients. CONCLUSIONS: The experience highlights the potential value of hypnosis in the management of anticipatory nausea and vomiting; furthermore, the susceptibility to anticipatory nausea and vomiting is discussed under the psychoanalytic point of view. Copyright 2000 S. Karger AG, Basel.
AIMS AND BACKGROUND: In addition to nausea and vomiting following chemotherapy treatment, cancerpatients can experience these side effects prior to a treatment session, the so-called anticipatory nausea and vomiting. As various psychological and neurophysiological aspects have been claimed to be implied in its etiopathogenesis, the present paper aims to shortly review the etiological, epidemiological and therapeutical assumptions on the topic, in particular the psychological-behavioral therapies. PATIENTS AND METHODS: The present study was carried out on 16 consecutive adult cancerpatients affected by chemotherapy-induced anticipatory nausea and vomiting who had received at least four treatment cycles. All of them were submitted to induction of relaxation followed by hypnosis. RESULTS: In all subjects anticipatory nausea and vomiting disappeared, and major responses to chemotherapy-induced emesis control were recorded in almost all patients. CONCLUSIONS: The experience highlights the potential value of hypnosis in the management of anticipatory nausea and vomiting; furthermore, the susceptibility to anticipatory nausea and vomiting is discussed under the psychoanalytic point of view. Copyright 2000 S. Karger AG, Basel.
Authors: Joseph A Roscoe; Michael O'Neill; Pascal Jean-Pierre; Charles E Heckler; Ted J Kaptchuk; Peter Bushunow; Michelle Shayne; Alissa Huston; Raman Qazi; Brian Smith Journal: J Pain Symptom Manage Date: 2010-06-25 Impact factor: 3.612
Authors: Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow Journal: Eur J Pharmacol Date: 2013-10-21 Impact factor: 4.432
Authors: Joseph A Roscoe; Gary R Morrow; Matti S Aapro; Alexander Molassiotis; Ian Olver Journal: Support Care Cancer Date: 2010-08-30 Impact factor: 3.603
Authors: Karen M Mustian; Katie Devine; Julie L Ryan; Michelle C Janelsins; Lisa K Sprod; Luke J Peppone; Grace D Candelario; Supriya G Mohile; Gary R Morrow Journal: US Oncol Hematol Date: 2011
Authors: L Lee Dupuis; Joseph A Roscoe; Ian Olver; Matti Aapro; Alexander Molassiotis Journal: Support Care Cancer Date: 2016-08-10 Impact factor: 3.603